CompletedNot Applicable

The Effect of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery

Switzerland200 participantsStarted 2009-01

Plain-language summary

The purpose of this study is to evaluate the cardioprotective effects of a short term infusion of glucose-insulin-potassium (GIK) during heart surgery.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Severe aortic stenosis * Coronary artery disease associated with poor left ventricular function * Parsonnet score \>7 Exclusion Criteria: * Dementia or inability to understand the study protocol * Off-pump and emergent cardiac surgery * Poorly controlled diabetes mellitus * Severe renal insufficiency * Abnormal liver function Child-Plugh - C * Body Mass Index \< 18 and \> 35

What they're measuring

Postcardiotomy ventricular dysfunction

Timeframe: 48h postoperative

Trial details

NCT IDNCT00788242

SponsorChristoph Ellenberger

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-12

View on ClinicalTrials.gov More Aortic Stenosis trials